Psychiatric diagnoses and comorbidities in a diverse, multicity cohort of young transgender women: Baseline Findings from Project LifeSkills

JAMA Pediatrics

Volumn 170, Issue 5, 2016, Pages 481-486

  Reisner, Sari L ^a,b,c   Biello, Katie B ^b,c,d   Hughto, Jaclyn M White ^c,e   Kuhns, Lisa ^f,g   Mayer, Kenneth H ^c,h   Garofalo, Robert ^f,g   Mimiaga, Matthew J ^b,c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c FENWAY INSTITUTE   (United States)

^d BROWN UNIVERSITY   (United States)

^e YALE UNIVERSITY   (United States)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ALCOHOLISM; ARTICLE; COMORBIDITY; GENERALIZED ANXIETY DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MALE TO FEMALE TRANSGENDER; MENTAL DISEASE; MENTAL HEALTH; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUICIDAL IDEATION; COMPLICATION; FEMALE; GENDER IDENTITY; ILLINOIS; MASSACHUSETTS; MENTAL DISORDERS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TRANSGENDER; TRANSSEXUALISM; YOUNG ADULT;

ADOLESCENT; ADULT; BOSTON; CHICAGO; FEMALE; GENDER IDENTITY; HUMANS; MALE; MENTAL DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TRANSGENDER PERSONS; TRANSSEXUALISM; YOUNG ADULT;

EID: 84962397567     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2016.0067     Document Type: Article

References (50)

1. Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAMHSA; 2013. HHS Publication (SMA) 13-4795.
2. Olson J, Forbes C, BelzerM. Management of the transgender adolescent. Arch Pediatr Adolesc Med. 2011;165(2):171-176.
3. Merikangas KR, He JP, BursteinM, et al. Lifetime prevalence of mental disorders in US adolescents: Results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989.
4. Reisner SL, Vetters R, LeclercM, et al. Mental health of transgender youth in care at an adolescent urban community health center. J Adolesc Health. 2015;56(3):274-279.
5. Olson J, Schrager SM, BelzerM, et al. Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria. J Adolesc Health. 2015;57(4):374-380.
6. Garofalo R, Deleon J, Osmer E, DollM, Harper GW. Overlooked, misunderstood and at-risk: Exploring the lives and HIV risk of ethnicminority male-to-female transgender youth. J Adolesc Health. 2006;38(3):230-236.
7. Edwards-Leeper L, Spack NP. Psychological evaluation and medical treatment of transgender youth in an interdisciplinary "gender management service" (GeMS) in a major pediatric center. J Homosex. 2012;59(3):321-336.
8. Coulter RW, Blosnich JR, Bukowski LA, et al. Differences in alcohol use and alcohol-related problems between transgender-and nontransgender-identified young adults. Drug Alcohol Depend. 2015;154:251-259.
9. Reisner SL, Greytak EA, Parsons JT, Ybarra ML. Gender minority social stress in adolescence: Disparities in adolescent bullying and substance use by gender identity. J Sex Res. 2015;52(3):243-256.
10. Rowe C, Santos G-M, McFarlandW, Wilson EC. Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015;147: 160-166.
11. Hotton AL, Garofalo R, Kuhns LM, Johnson AK. Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women. AIDS Educ Prev. 2013;25(1): 62-71.
12. Clements-Nolle K, Marx R, Guzman R, Katz M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons. Am J Public Health. 2001;91(6):915-921.
13. Clements-Nolle K, Marx R, KatzM. Attempted suicide among transgender persons: The influence of gender-based discrimination and victimization. J Homosex. 2006;51(3):53-69.
14. Keuroghlian AS, Reisner SL, White JM,Weiss RD. Substance use and treatment of substance use disorders in a community sample of transgender adults. Drug Alcohol Depend. 2015;152:139-146.
15. Reisner SL, White JM, Bradford JB, MimiagaMJ. Transgender health disparities: Comparing full cohort and nested matched-pair study designs in a community health center. LGBT Health. 2014;1(3): 177-184.
16. Benotsch EG, Zimmerman R, Cathers L, et al. Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults. Drug Alcohol Depend. 2013;132 (1-2):391-394.
17. Nuttbrock L, Hwahng S, BocktingW, et al. Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons. J Sex Res. 2010;47(1):12-23.
18. EatonWW, Anthony JC, Gallo J, et al. Natural history of diagnostic interview schedule/DSM-IV major depression: The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry. 1997;54(11):993-999.
19. Susser E, Schwartz S, Morabia A. Psychiatric Epidemiology: Searching for the Causes of Mental Disorders. New York, NY: Oxford University Press; 2006.
20. Center for Substance Abuse Treatment. Chapter 4: Screening and assessment. In: Substance Abuse Treatment: Addressing the Specific Needs of Women (Treatment Improvement Protocol [TIP] Series, No. 51.) Rockville, MD: Center for Substance Abuse Treatment; 2009.
21. Center for Substance Abuse Treatment. Chapter 4: Screening and assessment. In: Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol [TIP] Series, No. 57.) Rockville, MD: Center for Substance Abuse Treatment; 2014.
22. Stieglitz KA. Development, risk, and resilience of transgender youth. J Assoc Nurses AIDS Care. 2010;21(3):192-206.
23. Garofalo R, Johnson AK, Kuhns LM, et al. Life skills: Evaluation of a theory-driven behavioral HIV prevention intervention for young transgender women. J Urban Health. 2012;89(3):419-431.
24. LeungMW, Yen IH, Minkler M. Community based participatory research: A promising approach for increasing epidemiology's relevance in the 21st century. Int J Epidemiol. 2004;33(3):499-506.
25. Diagnostic and Statistical Manual of Mental Disorders. 4th text rev ed.Washington, DC: American Psychiatric Association; 2000:553-557.
26. International Classification of Diseases. 10th ed. Geneva, Switzerland:World Health Organization; 2009.
27. Sheehan DV, Lecrubier Y, Sheehan KH, et al. TheMini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33.
28. Gail MH, Benichou J. Encyclopedia of Epidemiologic Methods. Chichester, UK: Wiley; 2000.
29. Nock MK, Green JG, Hwang I, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: Results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry. 2013;70 (3):300-310.
30. McLaughlin KA, Koenen KC, Hill ED, et al. Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. J AmAcad Child Adolesc Psychiatry. 2013;52(8):815-830.e14.
31. Arnett JJ. Emerging adulthood: A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469-480.
32. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents. Biol Psychiatry. 2001;49(12):1002-1014.
33. Costello EJ, Pine DS, Hammen C, et al. Development and natural history of mood disorders. Biol Psychiatry. 2002;52(6):529-542.
34. Arnett JJ. The developmental context of substance use in emerging adulthood. J Drug Issues. 2005;35(2):235-254.
35. Sevelius JM. Gender affirmation: A framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11-12):675-689.
36. Vance SR Jr, Ehrensaft D, Rosenthal SM. Psychological and medical care of gender nonconforming youth. Pediatrics. 2014;134(6):1184-1192.
37. Coleman E, BocktingW, BotzerM, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.Int J Transgenderism. 2012;13(4):165-232.
38. Reisner SL, Bradford J, Hopwood R, et al. Comprehensive transgender healthcare: The gender affirming clinical and public health model of Fenway Health. J Urban Health. 2015;92(3):584-592.
39. Hoertel N, McMahon K, Olfson M, et al. A dimensional liability model of age differences in mental disorder prevalence. J Psychiatr Res. 2015; 64:107-113.
40. TegethoffM, Belardi A, Stalujanis E, Meinlschmidt G. Association between mental disorders and physical diseases in adolescents from a nationally representative cohort. Psychosom Med. 2015;77(3):319-332.
41. Gates GJ. Demographics and LGBT health. J Health Soc Behav. 2013;54(1):72-74.
42. Guss C, Shumer D, Katz-Wise SL. Transgender and gender nonconforming adolescent care: Psychosocial and medical considerations. Curr Opin Pediatr. 2015;27(4):421-426.
43. de Vries AL, McGuire JK, Steensma TD, et al. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014;134(4):696-704.
44. Steever J. Cross-gender hormone therapy in adolescents. Pediatr Ann. 2014;43(6):e138-e144.
45. Simons LK, Leibowitz SF, Hidalgo MA. Understanding gender variance in children and adolescents. Pediatr Ann. 2014;43(6):e126-e131.
46. Conron KJ, Landers SJ, Reisner SL, Sell RL. Sex and gender in the US health surveillance system. Am J Public Health. 2014;104(6):970-976.
47. Cochran BN, Peavy KM, Robohm JS. Do specialized services exist for LGBT individuals seeking treatment for substance misuse? Subst Use Misuse. 2007;42(1):161-176.
48. Rosenthal SM. Approach to the patient: Transgender youth: Endocrine considerations. J Clin Endocrinol Metab. 2014;99(12):4379-4389.
49. Costello EJ, Mustillo S, Erkanli A, et al. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60(8):837-844.
50. Kessler RC, ChiuWT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62 (6):617-627.